Yayınlar & Eserler

Yayın Ağı
Makaleler 5
Tümü (5)
SCI-E, SSCI, AHCI (4)
SCI-E, SSCI, AHCI, ESCI (5)
ESCI (1)
Scopus (5)

1. The Relationship Between Vitamin D and Euthyroid Sick Syndrome in Hospitalized Solid Cancer Patients: A Retrospective Study

Buyukbayram M. E., Hannarici Z., Turhan A., ÇAĞLAR A. A., ÇOBAN EŞDUR P., BİLİCİ M., et al.
Clinical Medicine Insights: Oncology , cilt.19, 2025 (SCI-Expanded) identifier identifier identifier

2. A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR)

Buyukbayram M. E., HANNARİCİ Z., TURHAN A., ÇAĞLAR A. A., ÇOBAN EŞDUR P., BİLİCİ M., et al.
BMC CANCER , cilt.24, sa.1, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier

3. Inflammatory parameters in NSCLC with driver mutation

Buyukbayram M. E., Hannarici Z., Yılmaz A., TURHAN A., ÇAĞLAR A. A., ÇOBAN EŞDUR P., et al.
LUNG CANCER MANAGEMENT , cilt.13, sa.1, 2024 (ESCI) identifier identifier identifier

4. The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker

Buyukbayram M. E., Hannarici Z., Duzkopru Y., TURHAN A., ÇAĞLAR A. A., Esdur P. C., et al.
Breast Cancer: Targets and Therapy , cilt.16, ss.329-339, 2024 (SCI-Expanded) identifier identifier identifier

5. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer

HANNARİCİ Z., Yilmaz A., Buyukbayram M. E., TURHAN A., ÇAĞLAR A. A., BİLİCİ M., et al.
FUTURE ONCOLOGY , cilt.19, sa.4, ss.315-325, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma identifier identifier identifier
Metrikler

Yayın

6

Yayın (WoS)

5

Yayın (Scopus)

5

Atıf (WoS)

1

H-İndeks (WoS)

1

Atıf (Scopus)

3

H-İndeks (Scopus)

1

Atıf (Scholar)

1

H-İndeks (Scholar)

1
BM Sürdürülebilir Kalkınma Amaçları